0620/24SCR019-18/R10
Media Highlights
From the 2024 ASCO® Annual Meeting
1
Media Outlet Article / Coverage
The ASCO Post David J. Andorsky, MD, on DLBCL and FL: New Data on Use of
Subcutaneous Epcoritamab
David Andorsky, MD
SCRI at Rocky Mountain Cancer Centers
Media Outlet Article / Coverage
Endpoints A Small Group of Melanoma Patients May Need Far Less
Immunotherapy with Surgery, Study Suggests
C. Lance Cowey, MD
SCRI at Texas Oncology
Media Outlet Article / Coverage
VuMedi ASCO® 2024 Insights: "ABBV-706 Study - Targeted ADC for
Advanced Solid Tumors"
Benjamin Garmezy, MD
SCRI
Continued ➔
